XML 61 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
Schedule of Income Tax Expense Determined at the U.S. Federal Income Tax Rate

A reconciliation of the income tax expense determined at the U.S. federal income tax rate to the Company’s actual income tax expense is as follows:

 

   For Year Ended December 31, 
   2023   2024   2025 
   US$   US$   US$ 
Loss before income tax expense   (6,120)   (5,886)   (6,454)
U.S. federal income tax rate   21%   21%   21%
Income tax benefit computed at the applicable tax rate   (1,285)   (1,236)   (1,355)
Expenses not deductible   555    726    5 
Effect of differences in corporate income tax rates   (60)   (216)   (324)
Change in valuation allowance   790    726    1,674 
Income tax expense            
Schedule of Deferred Tax Assets

The Group’s deferred tax assets on December 31, 2025 and 2024 were as follows:

 

   As of
December 31,
2024
   As of
December 31,
2025
 
   US$   US$ 
Deferred tax assets   3,755    5,428 
Less: valuation allowance   (3,755)   (5,428)
Deferred tax assets, net        
Schedule of Roll-Forward of the Valuation Allowance

The following represents a roll-forward of the valuation allowance:

 

   For the years ended December 31, 
   2023   2024   2025 
   US$   US$   US$ 
Beginning balance   2,238    3,029    3,755 
charge to tax expense in current year   790    726    1,674 
Ending balance   3,029    3,755    5,428